Cargando…

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis

Detalles Bibliográficos
Autores principales:	Huang, Wanxue, Sun, Gongrui, Wang, Qi, Long, Zhiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481238/ https://www.ncbi.nlm.nih.gov/pubmed/36119476 http://dx.doi.org/10.3389/fonc.2022.957370

Ejemplares similares

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia
por: Huang, Wanxue, et al.
Publicado: (2023)

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
por: Zhang, Wenwen, et al.
Publicado: (2021)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2021)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Management of Chronic Myeloid Leukemia and Pregnancy: A Bibliometric Analysis (2000-2020)
por: Wang, Yue, et al.
Publicado: (2022)

Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
por: Sun, Younguk, et al.
Publicado: (2018)

Acute Myeloid Leukemia as a Model for Cancer Therapy
por: Ravandi, Farhad
Publicado: (2012)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
por: Lu, Rui, et al.
Publicado: (2017)

The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia
por: Dembitz, Vilma, et al.
Publicado: (2021)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia
por: Manobianco, Steven A., et al.
Publicado: (2022)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia
por: Ramakrishnan, Anitha, et al.
Publicado: (2023)

Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
por: Arriazu, Elena, et al.
Publicado: (2016)

Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
por: Lamble, Adam J., et al.
Publicado: (2018)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
por: Wang, Yanyu, et al.
Publicado: (2022)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia
por: Han, Fei, et al.
Publicado: (2021)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
por: Magliulo, Daniela, et al.
Publicado: (2018)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Targeting the GFI1/1B—CoREST Complex in Acute Myeloid Leukemia
por: van Bergen, Maaike G. J. M., et al.
Publicado: (2019)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Targeting NAT10 Induces Apoptosis Associated With Enhancing Endoplasmic Reticulum Stress in Acute Myeloid Leukemia Cells
por: Zi, Jie, et al.
Publicado: (2020)

FBXW4 Is Highly Expressed and Associated With Poor Survival in Acute Myeloid Leukemia
por: Han, Qi, et al.
Publicado: (2020)

Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies
por: Pettit, Kristen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c7kt5te6in23m4kemi1iremkte